[CME: Familial Hypercholesterolemia - Statin Treatment during Pregnancy and Breastfeeding]

Pranvera Shala-Haskaj1, Franziska Krähenmann2, Dörthe Schmidt1

  • 1Klinik und Poliklinik für Innere Medizin, Universitätsspital Zürich.

Praxis
|April 30, 2020
PubMed

Insights

Familial hypercholesterolemia requires early statin treatment due to high cardiovascular risk. However, statin use during pregnancy and breastfeeding is limited, necessitating careful management and consultation with healthcare providers.

Area of Science:

  • Cardiology
  • Pharmacology
  • Genetics

Background:

  • Familial hypercholesterolemia (FH) presents a lifelong elevated cardiovascular risk.
  • Intensive statin therapy is crucial for managing FH.
  • Current guidelines on statin use during pregnancy and breastfeeding are limited and require clarification.

Purpose of the Study:

  • To review the current understanding and guidelines regarding statin treatment for familial hypercholesterolemia during pregnancy and breastfeeding.
  • To highlight the risks associated with statin use in pregnant and lactating women with FH.
  • To provide recommendations for managing FH in women of childbearing potential.

Main Methods:

  • Literature review of existing guidelines and studies on statin use in pregnancy.
  • Analysis of recommendations from bodies like NICE regarding conception, contraception, and lactation.
  • Summary of clinical considerations for unplanned pregnancies in FH patients.

Main Results:

  • NICE guidelines recommend discontinuing statins three months prior to conception to mitigate teratogenicity.
  • Contraception is advised during statin treatment for women with FH.
  • Lipid-lowering drugs are generally contraindicated until lactation ceases.

Conclusions:

  • Women with familial hypercholesterolemia must carefully manage statin therapy around conception and during pregnancy/breastfeeding.
  • Discontinuation of statins and medical consultation are essential in cases of unplanned pregnancy.
  • Further research is needed to establish definitive safety profiles for statin use in this population.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.2K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
263
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
1.2K
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
270
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
1.7K
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
186